Lisinopril + Telmisartan + Placebo
Phase 3Completed 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Kidney, Polycystic
Conditions
Kidney, Polycystic
Trial Timeline
Jan 1, 2006 → Jun 1, 2014
NCT ID
NCT00283686About Lisinopril + Telmisartan + Placebo
Lisinopril + Telmisartan + Placebo is a phase 3 stage product being developed by Merck for Kidney, Polycystic. The current trial status is completed. This product is registered under clinical trial identifier NCT00283686. Target conditions include Kidney, Polycystic.
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00283686 | Phase 3 | Completed |
| NCT01885559 | Phase 3 | Completed |
Competing Products
20 competing products in Kidney, Polycystic